MB Vaistų išplatinimo tiesioginė atstovybė Lietuvoje Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2022 |
---|
4,013 |
- |
410 |
389 |
- |
-0.28 |
-1.00 |
100.00 |
9.69 |
-1,111 |
1,114 |
0 |
3 |
2023 |
---|
5,074 |
- |
1,890 |
1,795 |
- |
0.13 |
0.21 |
100.00 |
35.38 |
684 |
146 |
0 |
830 |
2024 |
---|
4,825 |
- |
2,477 |
2,353 |
- |
0.63 |
0.04 |
100.00 |
48.77 |
3,037 |
125 |
0 |
3,162 |
Register and
explore Okredo data2024 |
---|
4,825 |
- |
2,477 |
2,353 |
- |
0.63 |
0.04 |
100.00 |
48.77 |
3,037 |
125 |
0 |
3,162 |
Register and
explore Okredo data2024
Turnover (€)
4,825 €-5 % *
Sales per employee (€)
-Profit before tax (€)
2,477 €31 % *
Net Profit (€)
2,353 €31 % *
Profit per employee (€)
-Working capital requirement
0.63 384.62 % *
Debt-to-equity ratio
0.04 -80.95 % *
Total profitability (%)
100.00 %0.00 % *
Net profitability (%)
48.77 %37.85 % *
Equity (€)
3,037 €344 % *
Amounts Payable And Liabilities (€)
125 €-14 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
3,162 €281 % *